Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Aldeyra Therapeutics (ALDX)
NASDAQ:ALDX
Aldeyra Therapeutics (ALDX) Financial Statements
1,273 Followers
Aldeyra Therapeutics Financial Overview
| Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | - | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -16.80M | $ -13.70M | $ -14.14M | $ -17.37M | $ -16.38M |
| EBITDA | $ -16.66M | - | $ -14.07M | $ -17.31M | $ -16.32M |
| Net Income Common Stockholders | $ -15.62M | $ -12.90M | $ -14.55M | $ -17.78M | $ -16.79M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 0.00 | $ 29.88M | $ 185.33M | $ 196.69M | $ 216.87M |
| Total Assets | $ 168.21M | $ 181.27M | $ 189.69M | $ 201.02M | $ 222.69M |
| Total Debt | $ 16.11M | $ 16.08M | $ 15.94M | $ 15.91M | $ 15.89M |
| Net Debt | $ 16.11M | $ -13.80M | $ -169.39M | $ -180.78M | $ -200.98M |
| Total Liabilities | $ 30.98M | $ 181.29M | $ 27.50M | $ 26.99M | $ 32.00M |
| Stockholders Equity | $ 137.24M | $ 151.01M | $ 162.19M | $ 174.03M | $ 190.69M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -9.44M | $ -11.23M | $ -12.57M | $ -19.96M | $ -12.89M |
| Operating Cash Flow | $ -9.44M | $ -11.23M | $ -12.57M | $ -19.96M | $ -12.87M |
| Investing Cash Flow | $ 30.00M | $ 27.00M | $ 19.02M | $ -17.94M | $ -58.03M |
| Financing Cash Flow | $ 52.56K | - | $ 1.20M | $ 0.00 | $ 23.32K |